Alternatives to NewStem

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Computational platform using LLMs trained on biological and chemical data for drug discovery.